BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21825147)

  • 21. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
    Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
    PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.
    Somanath PR; Malinin NL; Byzova TV
    Angiogenesis; 2009; 12(2):177-85. PubMed ID: 19267251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.
    Goyal A; Pal N; Concannon M; Paul M; Doran M; Poluzzi C; Sekiguchi K; Whitelock JM; Neill T; Iozzo RV
    J Biol Chem; 2011 Jul; 286(29):25947-62. PubMed ID: 21596751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides.
    Bazzazi H; Zhang Y; Jafarnejad M; Popel AS
    J Theor Biol; 2018 Oct; 455():212-221. PubMed ID: 30036530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
    Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF.
    Masson-Gadais B; Houle F; Laferrière J; Huot J
    Cell Stress Chaperones; 2003; 8(1):37-52. PubMed ID: 12820653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
    Wang J; Yang L; Liang F; Chen Y; Yang G
    J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells.
    Swiatkowska M; Szymański J; Padula G; Cierniewski CS
    FEBS J; 2008 Apr; 275(8):1813-23. PubMed ID: 18331351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation.
    Silverman AP; Kariolis MS; Cochran JR
    J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch.
    West XZ; Meller N; Malinin NL; Deshmukh L; Meller J; Mahabeleshwar GH; Weber ME; Kerr BA; Vinogradova O; Byzova TV
    PLoS One; 2012; 7(2):e31071. PubMed ID: 22363548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3.
    Zhong L; Tang L; He X
    Bioengineered; 2022 Feb; 13(2):2971-2980. PubMed ID: 35038961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis.
    Robinson SD; Reynolds LE; Kostourou V; Reynolds AR; da Silva RG; Tavora B; Baker M; Marshall JF; Hodivala-Dilke KM
    J Biol Chem; 2009 Dec; 284(49):33966-81. PubMed ID: 19837659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of αvβ3/VEGFR2 Axis.
    Helal-Neto E; Brandão-Costa RM; Saldanha-Gama R; Ribeiro-Pereira C; Midlej V; Benchimol M; Morandi V; Barja-Fidalgo C
    J Cell Physiol; 2016 Nov; 231(11):2464-73. PubMed ID: 27420801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro.
    Jarad M; Kuczynski EA; Morrison J; Viloria-Petit AM; Coomber BL
    BMC Cell Biol; 2017 Jan; 18(1):10. PubMed ID: 28114883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
    Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
    J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heteromultivalent targeting of integrin α
    Jia T; Choi J; Ciccione J; Henry M; Mehdi A; Martinez J; Eymin B; Subra G; Coll JL
    Biomaterials; 2018 Feb; 155():64-79. PubMed ID: 29169039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition.
    Dos Santos PK; Altei WF; Danilucci TM; Lino RLB; Pachane BC; Nunes ACC; Selistre-de-Araujo HS
    Biochimie; 2020 Jul; 174():144-158. PubMed ID: 32360415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
    Hall H; Hubbell JA
    Microvasc Res; 2004 Nov; 68(3):169-78. PubMed ID: 15501236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.